540 related articles for article (PubMed ID: 12488241)
1. Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivo.
Kalderon B; Mayorek N; Ben-Yaacov L; Bar-Tana J
Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E795-803. PubMed ID: 12488241
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
Okuno A; Tamemoto H; Tobe K; Ueki K; Mori Y; Iwamoto K; Umesono K; Akanuma Y; Fujiwara T; Horikoshi H; Yazaki Y; Kadowaki T
J Clin Invest; 1998 Mar; 101(6):1354-61. PubMed ID: 9502777
[TBL] [Abstract][Full Text] [Related]
3. Long-term pioglitazone treatment enhances lipolysis in rat adipose tissue.
Pravenec M; Kazdová L; Maxová M; Zídek V; Mlejnek P; Simáková M; Kurtz TW
Int J Obes (Lond); 2008 Dec; 32(12):1848-53. PubMed ID: 18936763
[TBL] [Abstract][Full Text] [Related]
4. Sensitization to insulin induced by beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in obese Zucker rats in vivo.
Mayorek N; Kalderon B; Itach E; Bar-Tana J
Diabetes; 1997 Dec; 46(12):1958-64. PubMed ID: 9392480
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone reduces free fatty acid-induced insulin resistance in perfused rat hindquarter.
Mokuda O; Sakamoto Y
Diabetes Metab; 1998 Sep; 24(4):362-4. PubMed ID: 9805648
[TBL] [Abstract][Full Text] [Related]
6. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.
Carpentier AC; Frisch F; Cyr D; Généreux P; Patterson BW; Giguère R; Baillargeon JP
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E849-56. PubMed ID: 15972273
[TBL] [Abstract][Full Text] [Related]
7. Effects of a 3-day fast on regional lipid and glucose metabolism in human skeletal muscle and adipose tissue.
Gjedsted J; Gormsen LC; Nielsen S; Schmitz O; Djurhuus CB; Keiding S; Ørskov H; Tønnesen E; Møller N
Acta Physiol (Oxf); 2007 Nov; 191(3):205-16. PubMed ID: 17784905
[TBL] [Abstract][Full Text] [Related]
8. Thiazolidinediones attenuate lipolysis and ameliorate dexamethasone-induced insulin resistance.
He J; Xu C; Kuang J; Liu Q; Jiang H; Mo L; Geng B; Xu G
Metabolism; 2015 Jul; 64(7):826-36. PubMed ID: 25825274
[TBL] [Abstract][Full Text] [Related]
9. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
Oakes ND; Thalén PG; Jacinto SM; Ljung B
Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
[TBL] [Abstract][Full Text] [Related]
10. Thiazolidinediones enhance insulin-mediated suppression of fatty acid flux in type 2 diabetes mellitus.
Racette SB; Davis AO; McGill JB; Klein S
Metabolism; 2002 Feb; 51(2):169-74. PubMed ID: 11833043
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid cycling in the fasting rat.
Kalderon B; Mayorek N; Berry E; Zevit N; Bar-Tana J
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E221-7. PubMed ID: 10893343
[TBL] [Abstract][Full Text] [Related]
12. Regulation of leptin release by troglitazone in human adipose tissue.
Fain JN; Cowan GS; Buffington C; Andersen RN; Pouncey L; Bahouth SW
Metabolism; 2000 Nov; 49(11):1485-90. PubMed ID: 11092516
[TBL] [Abstract][Full Text] [Related]
13. Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients.
Gastaldelli A; Casolaro A; Ciociaro D; Frascerra S; Nannipieri M; Buzzigoli E; Ferrannini E
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E225-30. PubMed ID: 19417125
[TBL] [Abstract][Full Text] [Related]
14. Contribution of altered lipolysis and reesterification in perturbations of free fatty acid kinetics during burn shock.
Robinson KM; Miller HI
Adv Shock Res; 1981; 5():27-36. PubMed ID: 7304329
[TBL] [Abstract][Full Text] [Related]
15. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites.
Lam TK; van de Werve G; Giacca A
Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E281-90. PubMed ID: 12531742
[TBL] [Abstract][Full Text] [Related]
16. Glucose-dependent insulin modulation of oscillatory lipolysis in perifused rat adipocytes.
Getty-Kaushik L; Richard AM; Corkey BE
Obes Res; 2005 Dec; 13(12):2058-65. PubMed ID: 16421338
[TBL] [Abstract][Full Text] [Related]
17. [Studies on lipid mobilization in obesity without glucose intolerance. 1st communication. Noradrenaline-stimulated lipolysis].
Ratzmann KP; Paul I; Meyer LW; Müller F
Endokrinologie; 1975 Dec; 66(3):337-47. PubMed ID: 1212997
[TBL] [Abstract][Full Text] [Related]
18. Glycerol production in subcutaneous adipose tissue in lean and obese humans.
Jansson PA; Larsson A; Smith U; Lönnroth P
J Clin Invest; 1992 May; 89(5):1610-7. PubMed ID: 1569199
[TBL] [Abstract][Full Text] [Related]
19. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats.
Rivera L; Morón R; Sánchez M; Zarzuelo A; Galisteo M
Obesity (Silver Spring); 2008 Sep; 16(9):2081-7. PubMed ID: 18551111
[TBL] [Abstract][Full Text] [Related]
20. Effect of cyclonicate, a new hypolipemic drug, on lipolysis in vitro.
Tessari F; Caparrotta L; Gaion RM; Fassina G
Farmaco Sci; 1981 Dec; 36(12):1029-36. PubMed ID: 6274681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
